About Grindlays Pharma
Grindlays Pharma is a Healthcare company based in Mumbai (India) founded in 1979. It manufactures bulk drugs and drug intermediates for the pharmaceutical industry. It operates on a B2B model. The company has 12 employees. Its Indian entity Grindlays Pharmaceuticals Pvt Ltd reported revenue of ₹14.96 Cr. Its focus areas include Pharmaceuticals, Drug Manufacturing and Bulk Drugs. Similar companies include Laurus Labs, Symbiotec and SeQuent; 2 of its 3 listed similar companies have raised funding.
Company details
Grindlays Pharma manufactures bulk drugs and drug intermediates for the pharmaceutical industry through providing healthcare solutions, producing pharmaceutical products, drug manufacturing, and bulk drugs. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field. It continues to evolve, meeting industry challenges with strategic approaches.
- Headquarters Mumbai, India
- Employees 12
- SectorsHealthcare
- Email••••••••
- Website grinpharma.com
- Legal Name Grindlays Pharmaceuticals Pvt Ltd
- Date of Incorporation 04 Sep, 1985
- Jurisdiction Mumbai, Maharashtra, India
- Annual Revenue₹14.96 Cr
FY 2025 · +69% YoY
- Net Profit₹13.8 Lakh
FY 2025 · 1% margin
- EBITDA₹73.7 Lakh
FY 2025 · 5% margin
- Employee Count12
Associated legal entities of Grindlays Pharma
Grindlays Pharma operates through Grindlays Pharmaceuticals Pvt Ltd (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Grindlays Pharmaceuticals Pvt Ltd CIN U99999MH1985PTC037368 | Active | 04 Sep 1985 | Mumbai, Maharashtra | ₹15.0 Cr | 12 | 4 | View details |
Board of directors of Grindlays Pharmaceuticals Pvt Ltd (Grindlays Pharma)
Grindlays Pharmaceuticals Pvt Ltd is the primary company behind Grindlays Pharma. The board of Grindlays Pharmaceuticals Pvt Ltd currently have 4 directors; the longest-serving is Ramkrishna Harishet Kolwankar, appointed in 1985. 1 earlier director has ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Ramkrishna Harishet Kolwankar DIN 00293905 | Managing Director | 15 Oct 1985 | 41 yrs | Grindlays Pharmaceuticals Pvt Ltd |
| Dhanashri Girish Gudi DIN 00294157 | Director | 31 Mar 1995 | 31 yrs 7 mo | Grindlays Pharmaceuticals Pvt Ltd |
| Arti Ramkrishna Kolwankar DIN 00300218 | Director | 01 Apr 1997 | 29 yrs 7 mo | Grindlays Pharmaceuticals Pvt Ltd |
| Santosh Ramkrishna Kolwankar DIN 00293852 | Director | 16 Nov 2009 | 16 yrs 11 mo | Grindlays Pharmaceuticals Pvt Ltd |
People of Grindlays Pharma
1 people are tracked at Grindlays Pharma (1 in leadership); the tracked headcount is 12.
| Name | Role | Group |
|---|---|---|
| Owner | Leadership |
Complete people profiles for Grindlays Pharma
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Grindlays Pharma
Figures of Grindlays Pharmaceuticals Pvt Ltd, the primary company behind Grindlays Pharma, for FY 2025. Revenue was ₹14.96 Cr (+69% year on year). Net profit was ₹13.8 Lakh (1% margin). EBITDA was ₹73.7 Lakh (5% margin). Revenue has grown at a compounded annual rate of -14% over three years and -5% over five years.
- ₹14.96 CrRevenue · FY 2025 · +69% YoY
- ₹13.8 LakhNet profit · 1% margin
- ₹73.7 LakhEBITDA · 5% margin
- ₹1.00 CrPaid-up capital
- 12Employees (provident fund records)
- -14%Revenue CAGR, 3 years
- -5%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Grindlays Pharmaceuticals Pvt Ltd are on its company page.
Detailed financial statements for Grindlays Pharma
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Similar companies to Grindlays Pharma
Grindlays Pharma has 3 listed similar companies in our database, 2 of them funded. They include Laurus Labs, Symbiotec and SeQuent.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| lauruslabs.com | 2005 | Hyderabad, India | $229.73M | 6,035 | Pharmaceutical and biotechnology company | |
| symbiotec.in | 2002 | Indore, India | $61.01M | 1,822 | Non-sterile steroid hormone-based APIs and intermediates are manufactured. | |
| sequent.in | 2002 | Bengaluru, India | APIs are developed and manufactured for therapeutic areas. |
Detailed similar companies of Grindlays Pharma
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Grindlays Pharma
Grindlays Pharma was founded in 1979.
Grindlays Pharma is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
Grindlays Pharma has 12 employees.
The primary company behind Grindlays Pharma, Grindlays Pharmaceuticals Pvt Ltd, reported revenue of ₹14.96 Cr for FY 2025, up 69% year on year.
Grindlays Pharma manufactures bulk drugs and drug intermediates for the pharmaceutical industry through providing healthcare solutions, producing pharmaceutical products, drug manufacturing, and bulk drugs. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field. It continues to evolve, meeting industry challenges with strategic approaches.
Grindlays Pharma's top competitors include Laurus Labs, Symbiotec and SeQuent.
Grindlays Pharma operates through Grindlays Pharmaceuticals Pvt Ltd.
The legal entities of Grindlays Pharma currently have 4 directors, including Arti Ramkrishna Kolwankar, Ramkrishna Harishet Kolwankar, Santosh Ramkrishna Kolwankar and others.